Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma

September 10, 2026 · 4:40 pm 1 sources

Image: Phys.org

Coverage

More coverage

• Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
  Phys.org · September 10, 2026 16:40
  Glioblastoma is one of the most aggressive and treatment-resistant brain cancers known to medicine, carrying a median survival of just 12–15 months, even with the best available care.